Evotec Stock - weekly sector review after quiet news flow
19.06.2026 - 17:11:54 | ad-hoc-news.de
Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 17:07 CET. Details in the imprint.
Evotec (DE0005664809) enters the weekend without a new market-moving release from the company or major wire services. With the news flow muted, this Friday review places the stock in its European biotech peer group and looks at key valuation and consensus markers.
All news and data on Evotec stock
Background pieces, quotes and corporate disclosures on Evotec are bundled in the dedicated topic section on ad-hoc-news.de.
How Evotec compares this week
In the absence of fresh headlines, Evotec sits in a broader European biotech sector that has seen cautious trading, with many development-stage names still below their 2021 peaks according to sector data from MarketScreener.
Evotec operates a partnering-heavy model and is often grouped with mid-cap contract research and discovery players, a space where investor appetite has been selective and focused on visible pharma tie-ups.
Peer group and valuation context
On Xetra, Evotec shares recently changed hands around the mid-single-digit euro range, giving the company a market capitalization in the lower single-digit billion-euro bracket according to exchange data.
This puts Evotec below large-cap drug developers but above many single-asset biotechs, underlining its hybrid position between service provider and pipeline owner that investors compare with other European drug-discovery platforms.
The product engine behind Evotec
Evotec generates revenue primarily by providing integrated drug discovery and development services, including screening, hit-to-lead, preclinical and early clinical support, often within multi-year alliances with global pharmaceutical and biotech partners.
Where the stock trades today
The shares of Evotec (DE0005664809) trade on Xetra at EUR 4.54 as of 06/19/2026, 17:07 CET.
Key facts on Evotec stock
- Company: Evotec SE
- ISIN: DE0005664809
- WKN: 566480
- Ticker: EVT
- Venue: Xetra
- Price (as of 06/19/2026, 17:07 CET): 4.54 EUR
- Market cap: 814,000,000 EUR (as of 06/19/2026)
- Sector / Industry: Health Care - Biotechnology
- Index membership: TecDAX, MDAX
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
